SPOCD1 and ovarian cancer: The results together suggest that GIP we generated possesses the ability to block SPOCD1-AS/G3BP1 interaction, suppress MMT process of MeT-5A cells, and restrains ovarian cancer peritoneal metastasis in vitro and in vivo.